Bp PLC Esperion Therapeutics, Inc. Transaction History

Bp PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 29, 2019	SELL	$40.1 - $52.33 $1.13 Million - $1.47 Million	-28,137 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$40.11 - $53.57 $1.13 Million - $1.51 Million	28,137 New	28,137 $1.13 Million
Q1 2018 Apr 26, 2018	SELL	$65.94 - $80.76 $1.23 Million - $1.5 Million	-18,624 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$43.47 - $67.43 $809,585 - $1.26 Million	18,624	18,624 $1.23 Million

199

136M

2.72M

1.3M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $144M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.